Michael S. Gilmore, PhD is currently the Sir William Osler Professor of Ophthalmology, and Microbiology and Immunobiology, Harvard Medical School. He serves on the steering committees of the Harvard Microbial Sciences Initiative, and the Infectious Disease Initiative of the Broad Institute of MIT and Harvard.
As Principal Investigator of the Harvard-wide Program on Antibiotic Resistance, his research focuses on the evolution and development of multidrug resistant strains of enterococci, staphylococci, and streptococci, and the development of new therapeutic approaches.
He is past chair of the NIH Bacterial Pathogenesis Study Section, the Gordon Conference on Microbial Adhesion and Signal Transduction, ASM Division D and the ARVO IM Section. He is founder and organizer of the international ASM Conference on Enterococci series, Editor in Chief of the public access book, Enterococci: From Commensals to Leading Causes of Drug Resistant Infection.
Mike started his academic career in 1984 at the University of Oklahoma Health Sciences Center, where he rose through the ranks to Vice President for Research. He also held the MG McCool professorship and the George Lynn Cross chair.
In 2004 he moved to Harvard Medical School to become the CL Schepens Professor of Ophthalmology, President and CEO of the Schepens Eye Research Institute, and Marie and DeWalt Ankeny Director of Research. In 2010, he moved his laboratories to their current location on the Massachusetts General Hospital campus of Harvard Medical School, in the Massachusetts Eye and Ear Infirmary. He continues to serve on numerous advisory boards and committees for public and private organizations, mainly focused on drug discovery, antibiotic resistance, and bacterial pathogenesis.